Amos Stemmer
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 7
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Salomon Marcello Stemmer (9 shared papers)Noa Eliakim‐Raz (7 shared papers)Yaara Leibovici Weissman (3 shared papers)Neta Ben-Chaim Moskovits (4 shared papers)Haim Ben‐Zvi (2 shared papers)Shlomit Yust‐Katz (2 shared papers)Adva Levy‐Barda (2 shared papers)Alona Zer (2 shared papers)
- Journals
- Cancers (3 papers)Annals of Oncology (2 papers)JAMA Oncology (2 papers)European Journal of Cancer (2 papers)Journal of Imaging Informatics in Medicine (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Amos Stemmer
19 papers receiving 484 citations
Peers
Comparison fields: 5 of 43
- Infectious Diseases 346
- Oncology 113
- Health Informatics 10
- Health 11
- Rheumatology 10
Countries citing papers authored by Amos Stemmer
This map shows the geographic impact of Amos Stemmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amos Stemmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amos Stemmer more than expected).
Fields of papers citing papers by Amos Stemmer
This network shows the impact of papers produced by Amos Stemmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amos Stemmer. The network helps show where Amos Stemmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Amos Stemmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 211 | |
| 2 | 2021 | 88 | |
| 3 | 2021 | 38 | |
| 4 | 2020 | 25 | |
| 5 | 2022 | 24 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 14 | |
| 8 | 2020 | 11 | |
| 9 | 2024 | 11 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 5 | |
| 16 | 2019 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2026 | 2 | |
| 19 | 2023 | 1 | |
| 20 | 2026 | 0 |
About Amos Stemmer
Amos Stemmer is a scholar working on Infectious Diseases, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 493 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cardiac Imaging and Diagnostics (2 papers), Breast Cancer Treatment Studies (2 papers), Artificial Intelligence in Healthcare (1 paper), Single-cell and spatial transcriptomics (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Infectious Diseases (346 citations), Oncology (113 citations), Health Informatics (10 citations), Health (11 citations) and Rheumatology (10 citations). Amos Stemmer has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Salomon Marcello Stemmer, Noa Eliakim‐Raz, Yaara Leibovici Weissman, Neta Ben-Chaim Moskovits, Haim Ben‐Zvi, Shlomit Yust‐Katz, Adva Levy‐Barda, Alona Zer, Alexandra Benouaich‐Amiel and Dafna Yahav. Their work appears in journals such as Cancers, Annals of Oncology, JAMA Oncology, European Journal of Cancer and Journal of Imaging Informatics in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.